Status:
COMPLETED
"How Blood Flow Restriction Exercise Affects Muscle Oxygenation and Lactate in Elite Athletes"
Lead Sponsor:
Eastern Mediterranean University
Conditions:
Blood Flow Restriction Training
Muscle Oxygenation
Eligibility:
MALE
15-18 years
Phase:
NA
Brief Summary
This study investigates the effects of blood flow restriction (BFR) training combined with low-intensity aerobic exercise on muscle oxygenation, total hemoglobin (THb), and blood lactate levels in eli...
Detailed Description
This comparative cross-sectional study aims to examine the acute physiological responses to low-intensity aerobic exercise combined with blood flow restriction (BFR) training in elite male track and f...
Eligibility Criteria
Inclusion
- Eligibility Criteria:
- Participants will be included or excluded based on the following conditions:
- Willingness to participate in the study
- Male individuals aged 15-18 years
- Sedentary status for control group participants (\<600 MET-min/week according to the International Physical Activity Questionnaire - Short Form)
- Body mass index (BMI) \<25 kg/m²
- Licensed track and field athlete for the study group
- At least 3 years of experience as a licensed sprint athlete
- No history of sports injury in the last 6 months
Exclusion
- Presence of open wounds or infection in the lower extremities
- Leg pain, varicose veins, or thrombophlebitis
- Diabetes or a history of cardiovascular disease
- Smoking and/or alcohol consumption
- Presence of respiratory distress
- Bilateral lower extremity pain and edema
- Incompatibility with the blood flow restriction (BFR) device
- Presence of diseases causing endothelial dysfunction (e.g., hypertension, cardiovascular diseases, neurological disorders, systemic inflammation, obesity, diabetes, atherosclerosis)
- History of deep vein thrombosis (DVT) or peripheral vascular disease
- Presence of acute infection
- History of cancer
- Surgical operation due to trauma within the last 6 months
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 19 2025
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06918314
Start Date
May 1 2024
End Date
March 19 2025
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Burcin Ugur Tosun
Famagusta, Cyprus, 99010